UCL Institute of Ophthalmology, University College London, London, UK.
Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Eur J Hum Genet. 2024 Dec;32(12):1583-1589. doi: 10.1038/s41431-024-01687-8. Epub 2024 Aug 21.
Corneal dystrophies are phenotypically and genetically heterogeneous, often resulting in visual impairment caused by corneal opacification. We investigated the genetic cause of an autosomal dominant corneal stromal dystrophy in a pedigree with eight affected individuals in three generations. Affected individuals had diffuse central stromal opacity, with reduced visual acuity in older family members. Histopathology of affected cornea tissue removed during surgery revealed mild stromal textural alterations with alcianophilic deposits. Whole genome sequence data were generated for four affected individuals. No rare variants (MAF < 0.001) were identified in established corneal dystrophy genes. However, a novel heterozygous missense variant in exon 4 of SPARCL1, NM_004684: c.334G > A; p.(Glu112Lys), which is predicted to be damaging, segregated with disease. SPARC-like protein 1 (SPARCL1) is a secreted matricellular protein involved in cell migration, cell adhesion, tissue repair, and remodelling. Interestingly, SPARCL1 has been shown to regulate decorin. Heterozygous variants in DCN, encoding decorin, cause autosomal dominant congenital stromal corneal dystrophy, suggesting a common pathogenic pathway. Therefore, we performed immunohistochemistry to compare SPARCL1 and decorin localisation in corneal tissue from an affected family member and an unaffected control. Strikingly, the level of decorin was significantly decreased in the corneal stroma of the affected tissue, and SPARCL1 appeared to be retained in the epithelium. In summary, we describe a novel autosomal dominant corneal stromal dystrophy associated with a missense variant in SPARCL1, extending the phenotypic and genetic heterogeneity of inherited corneal disease.
角膜营养不良在表型和基因型上具有异质性,常导致角膜混浊引起的视力损害。我们研究了一个三代共 8 名受影响个体的常染色体显性角膜基质营养不良家系的遗传病因。受影响个体有弥漫性中央基质混浊,老年家庭成员视力下降。手术切除的受影响角膜组织的组织病理学显示轻度基质纹理改变,伴嗜碱性沉积物。对 4 名受影响个体进行了全基因组序列数据生成。在已确立的角膜营养不良基因中未发现罕见变异(MAF<0.001)。然而,SPARCL1 外显子 4 中的一个新的杂合错义变异,NM_004684:c.334G>A;p.(Glu112Lys),预测为有害,与疾病共分离。SPARC 样蛋白 1(SPARCL1)是一种分泌的细胞外基质蛋白,参与细胞迁移、细胞黏附、组织修复和重塑。有趣的是,SPARCL1 已被证明可调节核心蛋白聚糖。编码核心蛋白聚糖的 DCN 中的杂合变异导致常染色体显性先天性基质性角膜营养不良,提示存在共同的致病途径。因此,我们进行了免疫组织化学染色,以比较受影响家庭成员和未受影响对照的角膜组织中 SPARCL1 和核心蛋白聚糖的定位。引人注目的是,受影响组织的角膜基质中核心蛋白聚糖的水平显著降低,而 SPARCL1 似乎保留在上皮中。总之,我们描述了一种与 SPARCL1 错义变异相关的新型常染色体显性角膜基质营养不良,扩展了遗传性角膜疾病的表型和遗传异质性。